argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia
First immune thrombocytopenia (ITP) plenary selection in 15 years underscores significant unmet need in this…
Keeper Security Delivers Structured Governance for Humans and AI Agents with New PAM Approval Workflows in KeeperPAM
Integrated Quantum Launches $10K Kaggle Hackathon to ‘Pierce the VEIL’
CleanStart Launches Cleansight To Uncover Hidden Container Risk And Map Vulnerabilities To Trusted Replacement Images